Daihan Pharmaceutical Co.,Ltd. (KOSDAQ: 023910)

Daihan Pharmaceutical Co.,Ltd. Statistics

Total Valuation

Daihan Pharmaceutical Co.,Ltd. has a market cap or net worth of KRW 150.23 billion. The enterprise value is 83.37 billion.

Market Cap	150.23B
Enterprise Value	83.37B

Important Dates

The last earnings date was Wednesday, November 13, 2024.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Daihan Pharmaceutical Co.,Ltd. has 5.88 million shares outstanding. The number of shares has decreased by -0.74% in one year.

Current Share Class	n/a
Shares Outstanding	5.88M
Shares Change (YoY)	-0.74%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	31.82%
Owned by Institutions (%)	16.73%
Float	4.01M

Valuation Ratios

The trailing PE ratio is 5.00.

PE Ratio	5.00
Forward PE	n/a
PS Ratio	0.76
PB Ratio	0.58
P/TBV Ratio	n/a
P/FCF Ratio	11.97
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 1.89, with an EV/FCF ratio of 6.64.

EV / Earnings	2.78
EV / Sales	0.42
EV / EBITDA	1.89
EV / EBIT	2.30
EV / FCF	6.64

Financial Position

The company has a current ratio of 3.23

Current Ratio	3.23
Quick Ratio	2.46
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 12.11% and return on invested capital (ROIC) is 9.12%.

Return on Equity (ROE)	12.11%
Return on Assets (ROA)	7.75%
Return on Capital (ROIC)	9.12%
Revenue Per Employee	358.14M
Profits Per Employee	54.31M
Employee Count	553
Asset Turnover	0.68
Inventory Turnover	4.81

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.85% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-5.85%
50-Day Moving Average	25,703.00
200-Day Moving Average	27,594.75
Relative Strength Index (RSI)	52.89
Average Volume (20 Days)	7,694

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Daihan Pharmaceutical Co.,Ltd. had revenue of KRW 198.05 billion and earned 30.04 billion in profits. Earnings per share was 5,107.91.

Revenue	198.05B
Gross Profit	67.03B
Operating Income	36.18B
Pretax Income	38.64B
Net Income	30.04B
EBITDA	44.06B
EBIT	36.18B
Earnings Per Share (EPS)	5,107.91

Balance Sheet

Cash & Cash Equivalents	66.86B
Total Debt	n/a
Net Cash	66.86B
Net Cash Per Share	11,370.70
Equity (Book Value)	259.85B
Book Value Per Share	44,191.97
Working Capital	87.71B

Cash Flow

In the last 12 months, operating cash flow was 36.32 billion and capital expenditures -23.77 billion, giving a free cash flow of 12.55 billion.

Operating Cash Flow	36.32B
Capital Expenditures	-23.77B
Free Cash Flow	12.55B
FCF Per Share	2,134.45

Margins

Gross margin is 33.84%, with operating and profit margins of 18.27% and 15.17%.

Gross Margin	33.84%
Operating Margin	18.27%
Pretax Margin	19.51%
Profit Margin	15.17%
EBITDA Margin	22.25%
EBIT Margin	18.27%
FCF Margin	6.34%

Dividends & Yields

This stock pays an annual dividend of 750.00, which amounts to a dividend yield of 2.94%.

Dividend Per Share	750.00
Dividend Yield	2.94%
Dividend Growth (YoY)	15.38%
Years of Dividend Growth	2
Payout Ratio	14.41%
Buyback Yield	0.74%
Shareholder Yield	3.68%
Earnings Yield	19.99%
FCF Yield	8.35%

Stock Splits

The last stock split was on April 29, 2002. It was a forward split with a ratio of 10.

Last Split Date	Apr 29, 2002
Split Type	Forward
Split Ratio	10

Scores

Daihan Pharmaceutical Co.,Ltd. has an Altman Z-Score of 4.69.

Altman Z-Score	4.69
Piotroski F-Score	n/a